Chemotherapy-induced hand-foot syndrome (HFS) is a common and distressing side effect experienced by patients undergoing cancer treatment. This condition, also known as palmar-plantar ...
The study covered in this summary was published on Research Square as a preprint and has not yet been peer reviewed. PLD is a key drug for platinum-resistant recurrent ovarian cancer but the risk for ...
The common side effect of hand-foot syndrome seen in patients taking capecitabine can be prevented by a cheap and safe topical gel containing 1% diclofenac, researchers reported in a study that has ...
A multi-center, open label trial to evaluate the efficacy and tolerability of aprepitant (A) and palonosetron (P) for the prevention of chemotherapy-induced nausea and vomiting in colorectal cancer ...
Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer Capecitabine, an oral ...
ORLANDO—Patients with metastatic renal cell carcincoma (RCC) who develop hand-foot syndrome (HFS) while being treated with sunitinib may have better progression-free survival and overall survival than ...
Hand-foot syndrome (HFS), or palmoplantar erythrodysesthesia, is a dermatological toxicity produced by the fluoropyrimidine chemotherapy agents capecitabine and fluorouracil and affects 43-71% of ...
Michael Allio made a promise to his late wife, Laura. He vowed to continue an initiative they started together — to help people reduce their pain from a common side effect of chemotherapy called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results